Mirador Therapeutics, Inc.

This study tests several new investigational drugs in 140 adults with moderate-to-severe Crohn's disease or ulcerative colitis. The goal is to see if these treatments are safe and can reduce gut inflammation, improve symptoms, and help the bowel heal. Participants will receive on…

This early-stage study tests the safety of a new drug called MT-201 in healthy adults aged 19 to 55. Researchers will give single or multiple doses to see how the body handles it and if any side effects occur. The goal is to gather initial safety information before testing in pat…

This early-stage study is testing a new drug, MT-251, in 70 healthy adults aged 19 to 55. The main goal is to check if the drug is safe and how the body processes it. Participants will receive either the drug or a placebo, and no direct health benefit is expected. The results wil…